Ajay Kuriyan, MD is a 2026 recipient of an Alcon Research Institute Senior Investigator Grant to execute his proposal - “Targeting Myofibroblasts and Their Progenitors to Prevent Retinal Detachment Secondary to Proliferative Vitreoretinopathy.” Congratulations to Dr. Kuriyan!
Mid Atlantic Retina
@MidAtl_Retina
Wills Eye Retina Doctors providing the latest treatments for retina, macula, and vitreous diseases in PA, NJ, DE.
Disclaimer: bit.ly/MARTermsOfUse
Disclaimer: bit.ly/MARTermsOfUse
380 Following 1.3K Followers 1.6K Posts
Latest posts 5
Offering the same world-class care in a brand new location; our newest office is opening in Newark, Delaware on November 23! We are scheduling new and existing patients. Visit our website for more information and to request an appointment. midatlanticretina.com/2026/11/06/new…
Current therapies for wet AMD can preserve and improve vision, but long-term vision loss remains a concern. Sunir Garg, MD, identifies submacular fibrosis, affecting up to one-third of patients in some studies, as a major unmet need. bit.ly/3Wo5daO
In anticipation of the 2026 AAO Annual Meeting, Sunir Garg, MD, describes how intravitreal TKI are evaluated in wet AMD to suppress VEGF signaling and modulate inflammatory pathways; which may offer a durable option for patients with recalcitrant disease. medscape.com/viewarticle/md…
“What we don’t want is for patients to be so fearful of these medicines." Sunir Garg, MD, weighs in on the GLP-1 medication vision loss lawsuit. Read more - today.com/health/news/vi…